Spontaneous regression of neuroblastoma
- PMID: 1030781
Spontaneous regression of neuroblastoma
Abstract
Case of spontaneous regression of neuroblastoma continue to occur in the present multimodal therapy era at institutions where physicians are prepared to withhold treatment on certain patients with residual primary or metastatic disease. From a survey of the 22 member institutions of Children's Cancer Study Group, seven hospitals submitted data on 24 neuroblastoma patients whose disease underwent regression after minimal, unusual, or no treatment. An analysis of these patients and of 33 patients form two large series in the literature shows that the majority of patients are infants with Stage II or Stage IVS disease. The spontaneous regression usually consists of complete disappearance of the disease, but in some neuroblastomas, maturation to ganglioneuroma takes place. The various factors that may influence regression are discussed.
Similar articles
-
Connatal localized neuroblastoma. The case to delay treatment.Cancer. 1996 Apr 1;77(7):1395-401. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1395::AID-CNCR26>3.0.CO;2-W. Cancer. 1996. PMID: 8608521
-
[Spontaneous regression of neuroblastoma. Review of biologic and immunologic causes of recovery].Kinderarztl Prax. 1973 Jan;41(1):23-30. Kinderarztl Prax. 1973. PMID: 4691735 German. No abstract available.
-
Maturation of mass-screened localized adrenal neuroblastoma.J Pediatr Surg. 2001 Nov;36(11):1633-6. doi: 10.1053/jpsu.2001.27935. J Pediatr Surg. 2001. PMID: 11685689
-
Neuroblastoma sympathicum.Acta Univ Carol Med Monogr. 1984;106:1-133. Acta Univ Carol Med Monogr. 1984. PMID: 6391118 Review. No abstract available.
-
Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.Am J Pediatr Hematol Oncol. 1992 May;14(2):103-10. Am J Pediatr Hematol Oncol. 1992. PMID: 1530115 Review.
Cited by
-
Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Mol Cell Biol. 1989 Oct;9(10):4337-44. doi: 10.1128/mcb.9.10.4337-4344.1989. Mol Cell Biol. 1989. PMID: 2573830 Free PMC article.
-
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.Br J Cancer. 2006 Jul 3;95(1):49-55. doi: 10.1038/sj.bjc.6603212. Epub 2006 Jun 6. Br J Cancer. 2006. PMID: 16755292 Free PMC article.
-
Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.Pediatr Surg Int. 2008 Jan;24(1):101-5. doi: 10.1007/s00383-007-2033-4. Pediatr Surg Int. 2008. PMID: 17952444
-
Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.Cell Death Dis. 2020 Feb 6;11(2):102. doi: 10.1038/s41419-020-2303-9. Cell Death Dis. 2020. PMID: 32029721 Free PMC article.
-
Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.Jpn J Cancer Res. 1992 Feb;83(2):159-64. doi: 10.1111/j.1349-7006.1992.tb00081.x. Jpn J Cancer Res. 1992. PMID: 1555997 Free PMC article.